Teva Ruling Creates Medicare Drug 'Chaos,' Full DC Circ. Told

By Dorothy Atkins · October 2, 2026, 11:08 PM EDT

The federal government asked the full D.C. Circuit on Friday to reconsider a panel ruling allowing Teva to challenge Medicare's rules for deciding which drugs qualify for price negotiations, arguing the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Teva Pharmaceuticals USA, Inc., et al v. Robert Kennedy, Jr., et al

Case Number

25-5425

Court

Appellate - DC Circuit

Nature of Suit

2899 Other Statutes APA/Review Agency

Date Filed

November 30, 2025